SCHEMBL610484

SCHEMBL610484

CCCC(=O)NC(c1cccs1)c1cc([N+](=O)[O-])c2cccnc2c1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 12/20 1.00
ALOX12 P18054 12/20 1.00
MEN1 O00255 11/20 1.00
KMT2A Q03164 11/20 1.00
L3MBTL1 Q9Y468 10/20 1.00
TDP1 Q9NUW8 9/20 1.00
MAPT P10636 9/20 1.00
HTT P42858 9/20 1.00
SMN1; SMN2 Q16637 8/20 1.00
LMNA P02545 8/20 1.00
PSMD14 O00487 2/20 1.00
MMP2 P08253 2/20 1.00
TP53 P04637 1/20 1.00
MDM2 Q00987 1/20 0.88
GAA P10253 1/20 0.80
BLM P54132 1/20 0.79
NPSR1 Q6W5P4 2/20 0.75
NPC1 O15118 6/20 0.74
RAB9A P51151 6/20 0.74
HSP90AA1 P07900 4/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26241605 0.96 ALOX12 (0.92) KDM4EALOX12MEN1KMT2AL3MBTL1
SCHEMBL610895 0.94 ALOX12 (1.00) KDM4EALOX12MEN1KMT2AL3MBTL1
SCHEMBL608048 0.89 KDM4E (1.00) KDM4EALOX12MEN1KMT2AL3MBTL1
SCHEMBL1541934 0.88 ALOX12 (1.00) KDM4EALOX12MEN1KMT2AL3MBTL1
SCHEMBL609917 0.85 KDM4E (1.00) KDM4EALOX12MEN1KMT2AL3MBTL1
SCHEMBL609671 0.85 KDM4E (1.00) KDM4EALOX12MEN1KMT2AL3MBTL1
SCHEMBL2153921 0.85 KDM4E (0.77) KDM4EALOX12MEN1KMT2AL3MBTL1
SCHEMBL30876651 0.84 KDM4E (0.74) KDM4EALOX12MEN1KMT2AL3MBTL1
SCHEMBL2153870 0.84 KDM4E (0.74) KDM4EALOX12MEN1KMT2AL3MBTL1
SCHEMBL27196457 0.84 KDM4E (0.74) KDM4EALOX12MEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210198244-A1 SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2021-07-01 US claimed
US-20170334890-A1 SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2017-11-23 US claimed
US-20150210674-A1 SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2015-07-30 US claimed
US-9000009-B2 Small molecule activators of mitochondrial function THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2015-04-07 US claimed
WO-2010068767-A1 SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2010-06-17 WO claimed
US-11701374-B1 8-hydroxy quinoline derivatives for enhancing telomerase reverse transcriptase (TERT) expression SIERRA SCIENCES, INC. (US) 2023-07-18 US disclosed
US-20210198244-A1 SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2021-07-01 US disclosed
US-10745390-B2 Small molecule activators of mitochondrial function THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2020-08-18 US disclosed
US-20170334890-A1 SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2017-11-23 US disclosed
US-9695157-B2 Small molecule activators of mitochondrial function THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2017-07-04 US disclosed
US-20150210674-A1 SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2015-07-30 US disclosed
US-9000009-B2 Small molecule activators of mitochondrial function THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2015-04-07 US disclosed
US-20120041023-A1 SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2012-02-16 US disclosed
WO-2010068767-A1 SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2010-06-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150210674-A1 SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION TFAM, TFB2M, GFM1 KDM4E 4095/4885ALOX12 678/4885MEN1 4113/4885
US-11701374-B1 8-hydroxy quinoline derivatives for enhancing telomerase reverse transcriptase (TERT) expression TERT, TERF2, RNGTT KDM4E 1300/4885ALOX12 3130/4885MEN1 3550/4885
US-20170334890-A1 SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION TFAM, TFB2M, GFM1 KDM4E 4095/4885ALOX12 678/4885MEN1 4113/4885
US-20120041023-A1 SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION TFAM, TFB2M, GFM1 KDM4E 4129/4885ALOX12 768/4885MEN1 4050/4885
US-10745390-B2 Small molecule activators of mitochondrial function TFAM, TFB2M, GFM1 KDM4E 4095/4885ALOX12 678/4885MEN1 4113/4885
US-20210198244-A1 SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION TFAM, TFB2M, GFM1 KDM4E 4095/4885ALOX12 678/4885MEN1 4113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.